Evocalcet (trade name Orkedia) is a drug for the treatment of hyperparathyroidism.

[1] It acts as a calcium-sensing receptor agonist.

[2] In 2018, it was approved in Japan for treatment of secondary hyperparathyroidism in patients on dialysis.

This hormonal preparation article is a stub.

You can help Wikipedia by expanding it.